Hikma Pharmaceuticals PLC (HKMPY)
OTCMKTS · Delayed Price · Currency is USD
56.07
+1.51 (2.77%)
May 19, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Injectables
967.78M
Log In
Log In
Log In
Log In
Upgrade
Injectables Growth
4.48%
Log In
Log In
Log In
Log In
Upgrade
Generics
753.79M
Log In
Log In
Log In
Log In
Upgrade
Generics Growth
38.17%
Log In
Log In
Log In
Log In
Upgrade
Branded
574.39M
Log In
Log In
Log In
Log In
Upgrade
Branded Growth
2.39%
Log In
Log In
Log In
Log In
Upgrade
Other
16.89M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
60.07%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
United States
1.39B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
19.35%
Log In
Log In
Log In
Log In
Upgrade
Middle East and North Africa
294.44M
Log In
Log In
Log In
Log In
Upgrade
Middle East and North Africa Growth
-4.31%
Log In
Log In
Log In
Log In
Upgrade
Saudi Arabia
209.97M
Log In
Log In
Log In
Log In
Upgrade
Saudi Arabia Growth
7.76%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of the World
165.72M
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of the World Growth
-2.79%
Log In
Log In
Log In
Log In
Upgrade
Algeria
152.05M
Log In
Log In
Log In
Log In
Upgrade
Algeria Growth
41.88%
Log In
Log In
Log In
Log In
Upgrade
Egypt
74.82M
Log In
Log In
Log In
Log In
Upgrade
Egypt Growth
-19.86%
Log In
Log In
Log In
Log In
Upgrade
North America
18.50M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
8.85M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom Growth
36.25%
Log In
Log In
Log In
Log In
Upgrade